1. Hypoglycemic episodes in a case of Prementrual Dysphoric Disorder on sertraline.
- Author
-
Santra Dhali R, Banerjee P, Munshi S, and Chaudhuri PR
- Subjects
- Adult, Female, Humans, Selective Serotonin Reuptake Inhibitors pharmacology, Selective Serotonin Reuptake Inhibitors therapeutic use, Sertraline pharmacology, Sertraline therapeutic use, Hypoglycemia chemically induced, Premenstrual Dysphoric Disorder drug therapy, Selective Serotonin Reuptake Inhibitors adverse effects, Sertraline adverse effects
- Abstract
Sertraline is a selective serotonin reuptake inhibitor. It has been shown to blunt postprandial hyperglycemia in rats and to potentiate the hypoglycemic effects of sulfonylurea agents in humans. Here, we report a case of a 33-year-old nondiabetic patient with no history of glucose intolerance, who experienced multiple episodes of hypoglycemia that resolved after discontinuation of the drug. Healthcare professionals should consider sertraline among the possible causes of hypoglycemia occurring in patients receiving antidepressants.
- Published
- 2015
- Full Text
- View/download PDF